...payment and will be eligible for milestones and royalties. Further financial terms were not disclosed. Chronix Biomedical...

...of Pediatric Oncology, Hematology and Hemostaseology at the hospital. Howard Urnovitz, CEO and CSO of Chronix Biomedical...
...licensing. Martz, L. SciBX 4(6); doi:10.1038/scibx.2011.154 Published online Feb. 10, 2011 Companies and Institutions Mentioned Chronix Biomedical...

...200 healthy subjects showed that Chronix's serum DNA assay had 92% sensitivity and 100% specificity. Chronix Biomedical...

...200 healthy subjects showed that Chronix's serum DNA assay had 92% sensitivity and 100% specificity. Chronix Biomedical...

...tool and later hopes to commercialize the test to monitor patient response to MS treatment. Chronix Biomedical...

...specificity and 90% sensitivity for diagnosing breast cancer. Data were published in Molecular Cancer Research. Chronix Biomedical...

...technologies with the institute's cellular nucleic acid detection platform, clinical samples and bovine genomics information. Chronix Biomedical Inc....

...rights to any Chronix technology related to urine-based diagnostics. Calypte Biomedical Corp. (CALY), Alameda, Calif. Chronix Biomedical Inc....